WHO advises against Gilead’s remdesivir for all hospitalised COVID-19 patients – Reuters

LONDON (Reuters) – Gileads drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need… [read more]

Leave a Comment